Xu Chen
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Oncology top 2%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 2%
- Topics
- Cancer-related molecular mechanisms research (29 papers)RNA modifications and cancer (28 papers)MicroRNA in disease regulation (24 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xu Chen
254 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Molecular Biology 3.9k
- Cancer Research 2.0k
- Oncology 1.2k
- Surgery 965
- Pulmonary and Respiratory Medicine 886
Countries citing papers authored by Xu Chen
This map shows the geographic impact of Xu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Chen more than expected).
Fields of papers citing papers by Xu Chen
This network shows the impact of papers produced by Xu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Chen. The network helps show where Xu Chen may publish in the future.
Co-authorship network of co-authors of Xu Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Xu Chen. A scholar is included among the top collaborators of Xu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Chen. Xu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 7 | |
| 3 | Stem cells vesicles-loaded type I pro-photosensitizer for synergetic oxygen-independent phototheranostics and microenvironment regulation in infected diabetic woundsbreakdown → | 17 |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 11 | |
| 9 | 0 | |
| 10 | 2 | |
| 11 | 45 | |
| 12 | 25 | |
| 13 | 76 | |
| 14 | 83 | |
| 15 | Fatty acid synthase enhances colorectal cancer cell proliferation and metastasis via regulating AMPK/mTOR pathway | 1 |
| 16 | 15 | |
| 17 | 180 | |
| 18 | Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion | 1 |
| 19 | 56 | |
| 20 | 136 |
About Xu Chen
Xu Chen is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 277 papers that have together received 6.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (29 papers), RNA modifications and cancer (28 papers) and MicroRNA in disease regulation (24 papers). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (3.9k citations) and Oncology (1.2k citations). Xu Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Tianxin Lin, Jian Huang, Ruihui Xie, Ming Huang, Wen Dong, Wang He, Guangzheng Zhong, Jinli Han, Ziyue Chen and Weibin Xie. Their work appears in journals such as Science, Nucleic Acids Research and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.